Skip to main content

Nevada To Get $285M In Opioid Settlement From Walgreens

Nevada To Get $285M In Opioid Settlement From Walgreens

Introduction

Nevada’s top attorney stated that the state of Nevada and Walgreens have negotiated a $285 million settlement over the pharmacy chain's contribution to the opioid crisis.

The final of many multiyear agreements with drug makers, merchants, and other parties, it brings Nevada's estimated payouts for opioid claims to $1.1 billion, according to a news release from the state's attorney general. The number of states that have achieved settlements, which now exceed $50 billion nationwide, includes Nevada.

According to the attorney general, one of his main concerns when he initially assumed office as attorney general was to seek justice for people who had been injured by the opioid crisis.

An email from a business spokesman stated that Walgreens had no comments on the settlement. The state sued in 2019, and Walgreens is the last defendant listed.

The state and the signatories of the One Nevada Agreement, a partnership of Nevada county and local governments, will share the $285 million settlement over 15 years.

About $98.1 million will be kept by the state, and it will go into a fund established to aid in funding opioid rehabilitation programmes run by the state Department of Health and Human Services. About $116.2 million will be given to the coalition.

The state agreed to pay Teva Pharmaceuticals $193 million in June, and CVS $152 million in May. A significant portion of the more than $50 billion acquired via countrywide settlements will be utilised to address an overdose issue connected to more than 100,000 fatalities each year in the United States.

In order to resolve litigation about the harm caused by opioids, CVS agreed to pay roughly $5 billion to state and municipal governments last year. But in order to seek the single-state settlement, Nevada chose not to participate in that case.

In April 2022, Nevada signed another multistate deal worth $232 million over almost two decades with three of the major opioid producers in the country.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!